Please use this identifier to cite or link to this item:
https://scidar.kg.ac.rs/handle/123456789/11023
Title: | Regulatory cytokines prescribe the outcome of the inflammation in the process of pseudoexfoliation production |
Authors: | Sarenac Vulovic, Tatjana Pavlović, Nenad Lutovac M. Zdravkovic, Vladimir Sreckovic M. Zdravkovic, Nemanja |
Issue Date: | 2019 |
Abstract: | Copyright © 2019, the Chinese Medical Association. Background: The purpose of this study is to reveal the participation of different regulatory cytokines within the process of pseudoexfoliation (PEX). Methods: Our study included 140 patients referred to cataract surgery with early and late stage of pseudoexfoliation syndrome (XFS) or pseudoexfoliation glaucoma (XFG). Humor and serum levels of cytokines: transforming growth factor beta (TGF-β), platelet- derived growth factor (PDGF), epidermal growth factor (EGF), insulin-like growth factor (IGF), IL-8 and interferon-inducible T cell alpha chemoattractant (ITAC) were measured in a sample using high sensitivity enzyme-linked immunoabsorbent assay (ELISA) kit. Results: Our results indicate that profibrotic action induced by increasing TGF-β and PDGF locally activates fibrous tissue production in the early XFS with a prolonged effect of PDGF (late XFS) and finally (XFG stage) it is dominantly controlled by EGF and IGF. ITAC overrides angiogenetic effects of IL-8 in XFG. Conclusion: Based on our findings, local chronic inflammation in the eye is accompanied by the secretion of different profibrotic cytokines (TGF-β, PDGF, EGF, IGF, IL-8) without angiogenesis due to effects of ITAC. |
URI: | https://scidar.kg.ac.rs/handle/123456789/11023 |
Type: | article |
DOI: | 10.1097/JCMA.0000000000000214 |
ISSN: | 1726-4901 |
SCOPUS: | 2-s2.0-85076315100 |
Appears in Collections: | Faculty of Medical Sciences, Kragujevac |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
PaperMissing.pdf Restricted Access | 29.86 kB | Adobe PDF | View/Open |
Items in SCIDAR are protected by copyright, with all rights reserved, unless otherwise indicated.